Abbott Laboratories recalls blood glucose meters

Abbott Laboratories is recalling its FreeStyle InsuLinx Blood Glucose Meters after finding that they display and store incorrect test results for dangerously high blood sugar levels.

The Abbott Park, Ill., company says the meters will display and store readings for of 1,024 milligrams per deciliter or higher at much lower levels. That's an extremely high and rare level that requires immediate medical attention.

The inaccurate readings can lead to a delay in identifying the problem or incorrect treatment. Abbott says that can lead to serious injury or death.

Abbott says customers with the meter should contact its diabetes care customer service or download a software update that resolves the issue.

Johnson & Johnson announced a similar recall last month for several types of its blood glucose meters.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Abbott recalls millions of diabetes testing strips

Dec 22, 2010

(AP) -- The Food and Drug Administration says Abbott Laboratories is recalling up to 359 million testing strips used by diabetics because they can give falsely low blood sugar readings.

Recommended for you

FDA OKs Cubist antibiotic for serious infections

7 hours ago

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.